Lab test picks winning cancer drugs for tough tumors
NCT ID NCT07468422
First seen Apr 02, 2026 · Last updated May 01, 2026 · Updated 4 times
Summary
This study tests a new lab method called OPTin that helps doctors choose the most effective drugs for people with advanced or hard-to-treat solid tumors. About 200 adults will provide a tumor sample for testing, then receive either a drug selected by OPTin or one chosen by their doctor. The goal is to see if OPTin-guided treatment leads to better tumor shrinkage or remission.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER (ADVANCED STAGE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China medical university hospital
Taichung, 40401, Taiwan
Conditions
Explore the condition pages connected to this study.